Glosario de términos de alcohol y drogas

T Babor, R Campbell, R Room, J Saunders

1994-01-01

Abstract:

What problem does this paper attempt to address?

Alcohol: No Ordinary Commodity-a summary of the third edition

Thomas F Babor,Sally Casswell,Kathryn Graham,Taisia Huckle,Michael Livingston,Jürgen Rehm,Robin Room,Ingeborg Rossow,Bundit Sornpaisarn

DOI: https://doi.org/10.1111/add.16003

Addiction

Abstract:Background and aims: This article summarizes the findings and conclusions of the third edition of Alcohol: No Ordinary Commodity. The latest revision of this book is part of a series of monographs designed to provide a critical review of the scientific evidence related to alcohol control policy from a public health perspective. Design: A narrative summary of the contents of the book according to five major issues. Findings: An extensive amount of epidemiological evidence shows that alcohol is a major contributor to the global burden of disease, disability and death in high-, middle- and low-income countries. Trends in alcohol products and marketing are described, indicating that a large part of the global industry has been consolidated into a small number of transnational corporations that are expanding their operations in Asia, Africa and Latin America. The main part of the book is devoted to a review of strategies and interventions designed to prevent or minimize alcohol-related harm. Overall, the most effective strategies to protect public health are taxation that decreases affordability and restrictions on the physical availability of alcohol. A total ban on alcohol marketing is also an effective strategy to reduce consumption. In addition, drink-driving counter-measures, brief interventions with at-risk drinkers and treatment of drinkers with alcohol dependence are effective in preventing harm in high-risk contexts and groups of hazardous drinkers. Conclusion: Alcohol policy is often the product of competing interests, values and ideologies, with the evidence suggesting that the conflicting interests between profit and health mean that working in partnership with the alcohol industry is likely to lead to ineffective policy. Opportunities for implementation of evidence-based alcohol policies that better serve the public good are clearer than ever before as a result of accumulating knowledge on which strategies work best.
Summary of poster abstract

DOI: https://doi.org/10.1111/acer.15317

2024-06-04

Alcoholism Clinical and Experimental Research

Abstract:Alcohol, Clinical and Experimental Research, Volume 48, Issue S1, Page 142-145, June 2024.

substance abuse
Agreement for Recovery: First Spanish Consensus on the Concept of Alcohol Addiction Recovery

Laura Esteban-Rodríguez,María Pérez-López,Ana Sion,Ruth Olmos-Espinosa,Rosa Jurado-Barba,Daniel Maldonado-Sánchez,Manuel León-Gayo,Víctor Armada,Gabriel Rubio

DOI: https://doi.org/10.62641/aep.v52i4.1633

Abstract:Introduction: Current literature does not dispose from a widely accepted definition of recovery in alcohol use disorder (AUD), and most proposals originate from anglophone countries. This study introduces a pioneering consensus in Spain on the definition of recovery in AUD. Method: The Delphi method was used. The expert panel, comprising 54 multidisciplinary professionals from the Community of Madrid. Results: A high level of consensus (≥80% agreement) was reached for 45% of the items and majority (≥60%) for 84%. Recovery is understood as a dynamic, personalized, and voluntary process, potentially enduring throughout one's lifespan. It entails a transformative lifestyle shift aimed at achieving a significant improvement in overall quality of life, encompassing physical and mental health, interpersonal relationships, and environmental factors. The journey of recovery is marked by heightened psychological well-being, is characterized by empowerment, personal growth, existential purpose, and positive identity reconstruction. Recovery is supported by substance use management, requires proactive individual agency and involves both personal and societal responsibilities. Conclusions: This study represents a milestone as it is the first consensus in the Community of Madrid on the meaning of recovery in AUD. The proposed definition of recovery could be a potential reference for similar regions within Spain or even for other countries with cultural similarities. The elucidation of a clear framework of recovery provides a solid basis for future research efforts and clinical interventions in the Spanish AUD landscape.
Introduction: Approved treatments for alcohol use disorder by regulatory agencies

Rosana Camarini,Fabio Cardoso Cruz

DOI: https://doi.org/10.1016/bs.irn.2024.07.001

2024-10-20

International Review of Neurobiology

Abstract:Alcohol, the most widely consumed substance globally, can lead to severe adverse effects for both users and those around them. Chronic ethanol consumption may lead to alcohol use disorder (AUD), a chronic relapsing condition characterized by compulsive drinking despite negative consequences. AUD is marked by a high relapse rate among individuals attempting abstinence. Currently, only a few medications, such as disulfiram, naltrexone, nalmefene, and acamprosate, are approved to treat AUD. Moreover, genetic factors and comorbid conditions can significantly influence both the development of AUD and the efficacy of its treatment. This chapter explores the genetic underpinnings of AUD and reviews the main pharmacological treatments available for managing this disorder.

neurosciences
Tipsy, trashed, or totalled? Lay understanding of dose-specific alcohol intoxication and the criminal justice system

Erica Martin,Celine van Golde,Alex M. T. Russell,Lauren A. Monds

DOI: https://doi.org/10.1080/1068316x.2024.2323466

2024-03-09

Psychology Crime and Law

Abstract:This online survey study explored how Australian laypeople ( N = 147) define alcohol intoxication using language, standard drinks, blood alcohol concentration (BAC), and symptoms. Participants used an extensive vocabulary to describe intoxication and better understood intoxication in terms of standard drinks and symptoms compared to BAC. Lay intoxication definitions and perceived alcohol-induced impairment thresholds (memory and capacity for consent) were influenced by personal characteristics (e.g. age, personal alcohol consumption). Participants rated symptom-based evidence as most useful when evaluating a person's intoxication status in a legal setting and welcomed expert evidence. Findings can inform litigation and educational strategies that facilitate accurate engagement with alcohol intoxication in the courtroom.

psychology, multidisciplinary,law,criminology & penology
Problems related to alcohol use: a cross-cultural perspective

O Gureje,V Mavreas,J L Vazquez-Barquero,A Janca

DOI: https://doi.org/10.1023/a:1005397700193

Abstract:The assessment, diagnosis, and classification of mental disorders are embedded in social and cultural norms. In view of their Anglo-Saxon origins, the prevailing diagnostic criteria and instruments for their assessment have a strong Western influence. Yet they are used internationally with the implied assumption of their cross-cultural applicability. The WHO Cross-Cultural Applicability Research (CAR) study was designed to test this assumption as it applies to disorders relating to the use of alcohol and drugs. This multi-disciplinary research project was conducted in nine countries having different patterns of alcohol and drug use. The results suggest that, even though some similarities exist with respect to the definition of problematic use of alcohol in these ethnically diverse societies, very substantial differences also exist. A number of core concepts underpinning diagnosis of disorders relating to the use of alcohol have no equivalence in the local languages of the various cultures, while some others lacked cultural applicability because of their relative 'distance' from cultural and ethnic norms of drinking. This distance often relates to the difficulties of adapting descriptors of drinking norms in a 'wet' culture to one that is decidedly 'dry'.
Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.

Richard L Bell,Kelle M Franklin,Sheketha R Hauser,Feng C Zhou

DOI: https://doi.org/10.2174/157488912800673155

2012-01-01

Recent Patents on CNS Drug Discovery

Abstract:This paper introduces the Special Section: Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence and provides a summary of patents targeting neurotransmitter systems not covered in the other four chapters. The World Health Organization notes that alcoholic-type drinking results in 2.5 million deaths per year, and these deaths occur to a disproportionately greater extent among adolescents and young adults. Developing a pharmacological treatment targeting alcohol abuse and dependence is complicated by (a) the heterogeneous nature of the disease(s), (b) alcohol affecting multiple neurotransmitter and neuromodulator systems, and (c) alcohol affecting multiple organ systems which in turn influence the function of the central nervous system. Presently, the USA Federal Drug Administration has approved three pharmacotherapies for alcoholism: disulfiram, naltrexone, and acamprosate. This chapter provides a summary of the following systems, which are not covered in the accompanying chapters; alcohol and acetaldehyde metabolism, opioid, glycinergic, GABA-A, neurosteroid, dopaminergic, serotonergic, and endocannabinoid, as well as patents targeting these systems for the treatment of alcoholism. Finally, an overview is presented on the use of pharmacogenetics and pharmacogenomics in tailoring treatments for certain subpopulations of alcoholics, which is expected to continue in the future.
General Pharmacology and Toxicology of Alcohol

T. L. Chruściel

DOI: https://doi.org/10.1007/978-3-642-67770-0_9

1982-01-01

Abstract:Ethyl alcohol (Alcohol aethylicus, C2H5OH) has been used since the dawn of history in various beverages and, much later in the history of mankind, as a pure fluid substance, for nonmedical, pseudomedical, and medical purposes. At one time it was considered an important remedy for all diseases: the word “whisky” is believed to have its roots in the Gaelic usquebough, meaning “water of life” (Ritchie, 1977). It is now recognized that the therapeutic value of alcohol is limited to its local external use; however, the social use of alcoholic beverages leading eventually to alcohol dependence and concurrent chronic intoxication, as well as frequently occurring cases of acute intoxication, calls for detailed knowledge of its pharmacology and toxicology.
AUD in perspective

Andrea de Bejczy,Giovanni Addolorato,Henri-Jean Aubin,Julien Guiraud,Esa R Korpi,David John Nutt,Katie Witkiewitz,Bo Söderpalm

DOI: https://doi.org/10.1016/bs.irn.2024.03.003

Abstract:Alcohol is a major cause of pre-mature death and individual suffering worldwide, and the importance of diagnosing and treating AUD cannot be overstated. Given the global burden and the high attributable factor of alcohol in a vast number of diseases, the need for additional interventions and the development of new medicines is considered a priority by the World Health Organization (WHO). As of today, AUD is severely under-treated with a treatment gap nearing 90%, strikingly higher than that for other psychiatric disorders. Patients often seek treatment late in the progress of the disease and even among those who seek treatment only a minority receive medication, mirroring the still-prevailing stigma of the disease, and a lack of access to effective treatments, as well as a reluctance to total abstinence. To increase adherence, treatment goals should focus not only on maintaining abstinence, but also on harm reduction and psychosocial functioning. A personalised approach to AUD treatment, with a holistic view, and tailored therapy has the potential to improve AUD treatment outcomes by targeting the heterogeneity in genetics and pathophysiology, as well as reason for, and reaction to drinking. Also, the psychiatric co-morbidity rates are high in AUD and dual diagnosis can worsen symptoms and influence treatment response and should be considered in the treatment strategies.
Novel medications for problematic alcohol use

Markus Heilig,Katie Witkiewitz,Lara A. Ray,Lorenzo Leggio

DOI: https://doi.org/10.1172/jci172889

IF: 19.456

2024-06-04

Journal of Clinical Investigation

Abstract:Alcohol-related harm, a major cause of disease burden globally, affects people along a spectrum of use. When a harmful pattern of drinking is present in the absence of significant behavioral pathology, low-intensity brief interventions that provide information about health consequences of continued use provide large health benefits. At the other end of the spectrum, profound behavioral pathology, including continued use despite knowledge of potentially fatal consequences, warrants a medical diagnosis, and treatment is strongly indicated. Available behavioral and pharmacological treatments are supported by scientific evidence but are vastly underutilized. Discovery of additional medications, with a favorable balance of efficacy versus safety and tolerability can improve clinical uptake of treatment, allow personalized treatment, and improve outcomes. Here, we delineate the clinical conditions when pharmacotherapy should be considered in relation to the main diagnostic systems in use and discuss clinical endpoints that represent meaningful clinical benefits. We then review specific developments in three categories of targets that show promise for expanding the treatment toolkit. GPCRs remain the largest category of successful drug targets across contemporary medicine, and several GPCR targets are currently pursued for alcohol-related indications. Endocrine systems are another established category, and several promising targets have emerged for alcohol indications. Finally, immune modulators have revolutionized treatment of multiple medical conditions, and they may also hold potential to produce benefits in patients with alcohol problems.

medicine, research & experimental
Alcohol and the Human Body

DOI: https://doi.org/10.1038/096675a0

IF: 64.8

1916-02-01

Nature

Abstract:IN this book, which has now reached a fifth edition, a striking array of statements and facts is marshalled on the deleterious effects of alcohol on the human body. The first chapter deals with the action of alcohol as a drug, the second with the chemistry of alcohol and of alcoholic beverages. The remainder of the book deals with the action and effects of alcohol—on the cell, on the various tissues and organs, on the metabolism of the body, and on the emotions. Concluding chapters discuss the relation of alcohol to disease and tropical conditions, and its use in the Services, and finally Dr. Arthur Newsholme sums up the influence of the drinking of alcoholic beverages on the national health.

multidisciplinary sciences
New therapeutics for the prevention or amelioration of fetal alcohol spectrum disorders: a narrative review of the preclinical literature

Montserrat Olivares-Costa,María Carolina Fabio,Erwin De la Fuente-Ortega,Paola A. Haeger,Ricardo Pautassi

DOI: https://doi.org/10.1080/00952990.2024.2361442

2024-07-20

The American Journal of Drug and Alcohol Abuse

Abstract:Background: Ethanol consumption during pregnancy induces enduring detrimental effects in the offspring, manifesting as a spectrum of symptoms collectively termed as Fetal Alcohol Spectrum Disorders (FASD). Presently, there is a scarcity of treatments for FASD. Objectives: To analyze current literature, emphasizing evidence derived from preclinical models, that could potentially inform therapeutic interventions for FASD. Methods: A narrative review was conducted focusing on four prospective treatments: nutritional supplements, antioxidants, anti-inflammatory compounds and environmental enrichment. The review also highlights innovative therapeutic strategies applied during early (e.g. folate administration, postnatal days 4–9) or late (e.g. NOX2 inhibitors given after weaning) postnatal stages that resulted in significant improvements in behavioral responses during adolescence (a critical period marked by the emergence of mental health issues in humans). Results: Our findings underscore the value of treatments centered around nutritional supplementation or environmental enrichment, aimed at mitigating oxidative stress and inflammation, implying shared mechanisms in FASD pathogenesis. Moreover, the review spotlights emerging evidence pertaining to the involvement of novel molecular components with potential pharmacological targets (such as NOX2, MCP1/CCR2, PPARJ, and PDE1). Conclusions: Preclinical studies have identified oxidative imbalance and neuroinflammation as relevant pathological mechanisms induced by prenatal ethanol exposure. The relevance of these mechanisms, which exhibit positive feedback loop mechanisms, appear to peak during early development and decreases in adulthood. These findings provide a framework for the future development of therapeutic avenues in the development of specific clinical treatments for FASD. Antecedentes: El consumo de etanol durante el embarazo induce efectos perjudiciales en la descendencia, manifestándose como un espectro de síntomas denominado Trastornos del Espectro Alcohólico Fetal (TEAF). Los tratamientos disponibles para el TEAF son muy escasos. Objetivos: Analizar la literatura actual, haciendo hincapié en evidencia derivada de modelos preclínicos, para informar y describir intervenciones terapéuticas nuevas para los TEAF. Métodos: Se desarrolló una revisión narrativa, centrada en cuatro tratamientos potenciales: suplementos nutricionales, antioxidantes, compuestos antiinflamatorios y enriquecimiento ambiental. También se revisaron estrategias terapéuticas innovadoras, aplicadas durante etapas postnatales tempranas (ej. administración de folato en días postnatales 4–9) o más tardías (ej. inhibidores de NOX2, dados después del destete) que resultan en mejoras significativas en las respuestas conductuales durante la adolescencia (un período crítico en humanos, donde surgen problemas de salud mental). Resultados: Los hallazgos subrayan el valor de tratamientos basados en suplementos nutricionales o en el enriquecimiento ambiental, para mitigar el estrés oxidativo y la neuroinflamación, lo que sugiere mecanismos compartidos en la patogénesis del TEAF. La revisión destaca evidencia relacionada con la participación de nuevos componentes moleculares con posibles blancos farmacológicos (ej. NOX2, MCP1/CCR2, PPARJ y PDE1). Conclusiones: Las investigaciones preclínicas han identificado el desequilibrio oxidativo y la neuroinflamación como mecanismos patológicos inducidos por la exposición prenatal al alcohol. La relevancia de estos mecanismos, que exhiben retroalimentación positiva, parece alcanzar su punto máximo durante el desarrollo temprano. Estos hallazgos proporcionan un marco conceptual para el desarrollo de tratamientos clínicos específicos para los TEAF.

substance abuse,psychology, clinical
Dynamic Pathways to Recovery from Alcohol Use Disorder

DOI: https://doi.org/10.1017/9781108976213

2021-11-30

Abstract:Alcohol use disorder is by far the most prevalent substance use disorder in the general population and is a major contributor to disease worldwide. Recovery from the disorder is a dynamic process of change, and individuals take many different routes to resolve their alcohol problems and seek to achieve a life worth living. Total abstention is not the only solution and robust recovery involves more than changing drinking practices. This volume brings together multidisciplinary research on recovery processes, contexts, and outcomes as well as new ideas about the multiple pathways involved. Experts chart the individual, social, contextual, community, economic, regulatory, policy, and structural influences that are vital to understanding alcohol use disorder and recovery. The book recommends new approaches to conceptualizing and assessing recovery alongside new avenues for research, community engagement, and policy that constitute a major shift in the practice and policy landscape.
Latent classes of gambling in youths: The role of comorbidity, alexithymia and stressful life events by sex

Laura Macía,Paula Jauregui,Iciar Iruarrizaga,Marta Herrero,Ana Estévez Gutiérrez

DOI: https://doi.org/10.20882/adicciones.1838

2024-06-26

Adicciones

Abstract:Alexithymia is related with propensity towards impulsive behavioral responses, rather than cognitive regulation of stressful events. Youth is a particularly vulnerable time for the confluence of these variables, which may impact the severity of gambling disorders (GD). However, sex differences have hardly been explored. This study aimed, firstly, to explore the frequency of GD among young people, as well as the presence of GD with other comorbid addictions. Secondly, latent classes were examined on the basis of gambling risk and their relationship to other addictive behaviors, alexithymia and stressful life events. Thirdly, we analyzed whether class membership was predicted by sex and age. The sample was composed of 360 participants between the ages of 18 and 35, the majority female. The results obtained revealed that alcohol abuse was the most prevalent addictive behavior both for problem and non-problem gamblers of both sexes. Group membership analyses showed the presence of two latent classes based on gambling risk. One of them was characterized by gambling risk, comorbidity, alexithymia, and stressful life events, and mainly predicted by being male. The other model was characterized by no gambling risk, lower levels of stressful life events and alexithymia, and mainly predicted by being female. This second profile presents a risk of alcohol abuse and compulsive buying. We highlight the need to introduce a gender perspective both in the interpretation of research findings and in the clinical application of treatments. CAST: La comorbilidad, la alexitimia y los acontecimientos vitales estresantes desempeñan un papel importante en la salud mental de los jóvenes. Este estudio ha tenido como objetivo, en primer lugar, explorar la frecuencia del trastorno de juego (TJ) en los jóvenes, así como la presencia del TJ con otras adicciones comórbidas. En segundo lugar, se pretendía analizar un modelo de perfil basado en el riesgo de juego y su relación con las otras conductas adictivas, la alexitimia y los acontecimientos vitales estresantes. En tercer lugar, se analizó si la pertenencia a cada perfil era predicha por el sexo y la edad. La muestra estaba compuesta por 360 participantes. Los resultados obtenidos revelaron que el abuso de alcohol era la conducta adictiva más prevalente tanto para los jugadores problemáticos como para los no problemáticos de ambos sexos. Los análisis de pertenencia de clase mostraron la presencia de dos modelos de perfil de juego. El primeor de ellos se caracterizaba por el riesgo de juego, la comorbilidad, la alexitimia y los acontecimientos vitales estresantes, y estaba principalmente predicho por la condición sexo-varón. El otro modelo se caracteriza por la ausencia de riesgo de juego, niveles más bajos de acontecimientos vitales estresantes y alexitimia, y se predice principalmente por ser mujer. En este segundo perfil hay riesgo de abuso de alcohol y de compra compulsiva. Destacamos la necesidad de introducir una perspectiva de género tanto en la interpretación de los resultados de la investigación como en la aplicación clínica de los tratamientos.
Genomics and epigenomics of substance use disorders: An introduction

Bru Cormand,Judit Cabana‐Domínguez,Diego A. Forero,Noèlia Fernàndez‐Castillo

DOI: https://doi.org/10.1002/ajmg.b.32844

2021-04-01

Abstract:Substance use disorders (SUD) are common conditions around the world, with important health and societal impacts, particularly in the burden of disease (disability-adjusted life years) (Whiteford, Ferrari, Degenhardt, Feigin, & Vos, <a class="bibLink tab-link" href="#ajmgb32844-bib-0017">2015</a>). The Global Burden of Disease Study estimated the global number of cases for SUD for several substances as follows: 94.8 million for alcohol, 17.2 million for amphetamine, 15.5 million for opioids, and 13.1 million for cannabis (Whiteford, 2015). In the United States, the lifetime and 12-month prevalences of SUD were 9.9% and 3.9%, respectively (Grant et al., <a class="bibLink tab-link" href="#ajmgb32844-bib-0006">2016</a>). In addition, polysubstance use is an important challenge in the field of addiction research (Whiteford et al., <a class="bibLink tab-link" href="#ajmgb32844-bib-0017">2015</a>).
Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol

Guillermo Burillo-Putze,Dima Ibrahim-Achi,Miguel Galicia,August Supervía,Lidia Martínez-Sánchez,Juan Ortega Pérez,Sebastián Matos Castro,Beatriz Martín-Pérez,M.ª Ángeles López Hernández,Òscar Miró

DOI: https://doi.org/10.55633/s3me/e048.2022

2024-07-29

Emergencias

Abstract:Objetivo. Investigar si existen diferencias en las manifestaciones clínicas por consumo de cannabis según la edad, y si estas se modifican en función del sexo o el consumo de etanol. Método. Estudio observacional descriptivo de pacientes atendidos en 11 servicios de urgencias con consumo de cannabis como motivo de consulta. Se recogieron 11 manifestaciones clínicas y se analizó su frecuencia relativa en función de la edad mediante curvas spline cúbicas restringidas. Se analizó si existía interacción en el comportamiento etario de cada uno de los síntomas en función del sexo y del consumo de etanol. Resultados. Se analizaron 949 pacientes, edad media 29 años, 74% varones y 39% con coingesta de etanol. Se identificaron tres patrones de síntomas según la edad: estable (vómitos, cefalea, convulsiones, hipotensión), incrementada en edades medias (agresividad-agitación, ansiedad, psicosis, palpitaciones, alucinaciones) y con aumento progresivo con la edad (dolor torácico e hipertensión). En la relación síntoma-edad, la frecuencia de palpitaciones, vómitos y cefalea tuvo un comportamiento significativamente diferente según el sexo, más constante en hombres y con un incremento marcado en edades medias en mujeres. La coingesta de etanol se asoció con más agitación-agresividad (34,0%/23,4%, p < 0,001) y menos palpitaciones (9,8%/15,6%, p = 0,01), ansiedad (20,7%/27,8%, p = 0,01), psicosis (10,3%/16,6%, p = 0,007) y dolor torácico (3,8%/9,5%, p = 0,001). En cuanto a la relación síntoma-edad, el etanol solo modificó significativamente la frecuencia de vómitos y de psicosis. Conclusión. La edad condiciona efectos clínicos diferenciales en algunas manifestaciones agudas de la intoxicación por cannabis que precisa asistencia hospitalaria, y el sexo y el consumo simultáneo de alcohol modifican esta relación entre edad y frecuencia de algunos síntomas.

emergency medicine
A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation

Mehdi Farokhnia,Sara L. Deschaine,Armin Sadighi,Lisa A. Farinelli,Mary R. Lee,Fatemeh Akhlaghi,Lorenzo Leggio

DOI: https://doi.org/10.1038/s41380-018-0287-y

IF: 11

2018-10-31

Molecular Psychiatry

Abstract:Previous studies suggest that GABA-B receptor agonism may represent an effective pharmacological approach to treat addictive disorders. Baclofen is a selective GABA-B receptor agonist which has been investigated as a potential treatment for alcohol use disorder. However, research is needed to understand the biobehavioral mechanisms underlying baclofen’s effect on alcohol use. In the present randomized, double-blind, placebo-controlled study, thirty-four alcohol-dependent individuals were randomized to receive baclofen (30 mg/d) or placebo for a week, and then participated in a laboratory experiment consisting of three procedures: alcohol cue-reactivity, priming, and self-administration. During the experiment, craving and other subjective responses to alcohol were assessed, and blood samples were collected for pharmacokinetic measurements. The effects of baclofen on the relationships between different alcohol-related laboratory parameters were investigated. Baclofen pharmacokinetic parameters and their correlations with behavioral measures were also examined. Results showed that baclofen disrupted the link between alcohol priming and self-administration, as indicated by significant interaction effects between drug condition (baclofen vs. placebo) and some of the priming variables (alcohol craving: F3,9 = 6.03, p = 0.01; alcohol sedation: F3,6 = 7.16, p = 0.01) on the total amount of alcohol self-administered. Considerable interindividual variability in baclofen pharmacokinetic parameters was observed. Maximum plasma concentrations of baclofen negatively correlated with cue-induced alcohol craving (r = −0.57, p = 0.03) and priming-induced ratings of ‘like more’ (r = −0.59, p = 0.02). In conclusion, baclofen may work by dissociating the link between an initial drink (priming) and subsequent alcohol consumption (self-administration). Considerable pharmacokinetic variability is an important factor to take into account when employing baclofen as a treatment for alcohol use disorder.

biochemistry & molecular biology,neurosciences,psychiatry
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.

G. Ragia,V. Manolopoulos

DOI: https://doi.org/10.2174/1389201018666170224105025

2017-02-28

Current Pharmaceutical Biotechnology

Abstract:Alcohol addiction or alcoholism is the most severe form of problem drinking. A variety of treatment methods for alcoholism are currently available that combine medications, behavioral treatment and peer support. The drugs that are currently approved by the U.S. Food and Drug Administration (FDA) for treatment of alcohol dependence are disulfiram, naltrexone and acamprosate. For many patients, however, these treatments are not effective. Evidence from a number of studies suggests that various factors, both psychosocial and economic, as well as genetic variation, are significant contributors to interindividual variation both of clinical presentation of alcohol problems and response to a given treatment. The aim of the present review is to summarize and discuss different aspects of personalized medicine of alcohol addiction. We focus on pharmacogenomics and beyond, to include the genetics and epigenetics of alcohol addiction as well as other psychosocial and even economic factors that may affect response to alcohol addiction pharmacotherapy. It is anticipated that, within the next 5-10 years, personalized medicine of alcohol addiction will be a reality and it will help reduce the burden of alcoholism from society and increase the well-being and productivity of individuals addicted to alcohol.

Medicine
S1845 A Cross-Sectional Study of Alcohol Awareness, Consumption Patterns, and Alcohol Related Disease in a Tertiary Center Liver Clinic

Sofi Damjanovska,Jenny Jan,Erica Graff,Daniel Karb,Seth Sclair,Stanley M. Cohen

DOI: https://doi.org/10.14309/01.ajg.0001036748.12985.9f

2024-10-26

The American Journal of Gastroenterology

Abstract:In the past decade in the United States there has been increase in alcohol related economic cost and mortality. We aim to identify alcohol awareness and consumption patterns in patients in liver clinics. Our hypothesis is that patients that lack knowledge of alcohol related complications will consume more alcohol and have alcohol related liver disease (ALD) as etiology of their chronic liver disease more often.

gastroenterology & hepatology
Needs and expectations of healthcare professionals regarding the topic of alcohology: Results of a survey conducted in France in 2022

Naouras Bouajila,Judith Andre,François Paille,Bernard Basset,Amine Benyamina,Ane Sylvie,Jacques Yguel,Romain Sicot,Mickael Naassila

DOI: https://doi.org/10.1016/j.jeph.2024.202772

2024-08-03

Abstract:Context: Alcohol-related health problems represent a significant public health concern, and it is imperative for the healthcare team to accurately perceive and detect these issues to provide appropriate care. The objective of this survey was to evaluate the knowledge, practices, and educational background of healthcare professionals in the field of alcohol-related health concerns, aiming to identify their information requirements. Methods: This study employs a cross-sectional descriptive survey methodology, in which data were gathered through a digital questionnaire designed for healthcare professionals (including those in medical, paramedical, and medico-social professions) working in addictology services as well as other relevant services across France and its overseas departments. Results: A total of 611 questionnaires were deemed usable for analysis. A considerable percentage of participants reported their knowledge and skills to be insufficient or very insufficient, with rates of 33 % and 36 %, respectively. Moreover, a significant proportion of respondents (≈ 28 %) stated that they had received no education in addictology. Our results highlight differences in levels of knowledge and competence among the various healthcare settings, notably with lower reported levels of satisfaction in hospital settings (public and private), private practice, and in Harm Reduction Centers. Furthermore, certain professions reported unsatisfactory levels of skills and knowledge in alcohol-related issues, particularly support staff, pharmacists, expert patients, administrative staff, and social workers. These findings suggest the need to enhance knowledge and skills by tailoring interventions according to the specific healthcare settings and professions. Additionally, the priority themes and channels for disseminating information varied depending on age, region, and professional category. Conclusion: This survey reveals a low level of knowledge, practice, and education in addictology, emphasizing the critical need for training. The importance of training extends not only to the priority topics addressed but also to the channels used for dissemination, all while customizing them to suit the age, professional category, structure, and region of healthcare professionals.

Glosario de términos de alcohol y drogas

Alcohol: No Ordinary Commodity-a summary of the third edition

Summary of poster abstract

Agreement for Recovery: First Spanish Consensus on the Concept of Alcohol Addiction Recovery

Introduction: Approved treatments for alcohol use disorder by regulatory agencies

Tipsy, trashed, or totalled? Lay understanding of dose-specific alcohol intoxication and the criminal justice system

Problems related to alcohol use: a cross-cultural perspective

Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.

General Pharmacology and Toxicology of Alcohol

AUD in perspective

Novel medications for problematic alcohol use

Alcohol and the Human Body

New therapeutics for the prevention or amelioration of fetal alcohol spectrum disorders: a narrative review of the preclinical literature

Dynamic Pathways to Recovery from Alcohol Use Disorder

Latent classes of gambling in youths: The role of comorbidity, alexithymia and stressful life events by sex

Genomics and epigenomics of substance use disorders: An introduction

Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol

A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation

Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.

S1845 A Cross-Sectional Study of Alcohol Awareness, Consumption Patterns, and Alcohol Related Disease in a Tertiary Center Liver Clinic

Needs and expectations of healthcare professionals regarding the topic of alcohology: Results of a survey conducted in France in 2022